Back to Search
CYNTHIA SPARROW, PHD
PHD
Clinical Psychologist
NPI: 1114043718Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
1687(DC)
Research & Publications (20)
Structural and biochemical characterization of the wild type PCSK9-EGF(AB) complex and natural familial hypercholesterolemia mutants.
PMID 19001363·J Biol Chem·2009
8-other
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.
PMID 18536749·Br J Pharmacol·2008
7-preclinical
Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation.
PMID 18391212·Proc Natl Acad Sci U S A·2008
8-other
Functional analysis of sites within PCSK9 responsible for hypercholesterolemia.
PMID 18354137·J Lipid Res·2008
8-other
Fluorogenic substrates for high-throughput measurements of endothelial lipase activity.
PMID 17090660·J Lipid Res·2007
7-preclinical
Copper beta-diketonate molecular squares and their host-guest reactions.
PMID 17640013·Angew Chem Int Ed Engl·2007
8-other
A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology.
PMID 17601482·Anal Biochem·2007
7-preclinical
Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.
PMID 17493938·J Biol Chem·2007
4-observational
Separation of an endodontic instrument: clinical significance.
PMID 16895008·J Tenn Dent Assoc·2006
6-review
SAR studies: designing potent and selective LXR agonists.
PMID 16529931·Bioorg Med Chem Lett·2006
7-preclinical
Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
PMID 16325781·Biochem Pharmacol·2006
4-observational
Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis.
PMID 16125384·Bioorg Med Chem Lett·2005
7-preclinical
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
PMID 15911262·Bioorg Med Chem Lett·2005
7-preclinical
A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis.
PMID 14701675·Endocrinology·2004
7-preclinical
Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors.
PMID 15090224·Assay Drug Dev Technol·2003
7-preclinical
Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis.
PMID 12615685·Arterioscler Thromb Vasc Biol·2003
7-preclinical
A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a).
PMID 12072387·Endocrinology·2002
4-observational
Deficiency in sPLA(2) does not affect HDL levels or atherosclerosis in mice.
PMID 12054745·Biochem Biophys Res Commun·2002
7-preclinical
A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux.
PMID 11790770·J Biol Chem·2002
8-other
Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate.
PMID 11641412·J Biol Chem·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 650 PENNSYLVANIA AVE SE, SUITE 410
WASHINGTON, DC 20003 - Phone
- (202) 544-0072
Quick Facts
- NPI
- 1114043718
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile